Sun Pharmaceutical Industries Ltd. (SUNPHARMA)
Market Closed
8 Dec, 10:00
XNSE XNSE Primary MSE ₹
1,796. 20
-9.1
-0.5%
₹
4.26T Market Cap
- P/E Ratio
20% Div Yield
2,410,070 Volume
- Eps
₹ 1,805.3
Previous Close Day Range
1,785.7 1,806
Year Range
1,548 1,910
Want to track SUNPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days
Summary
SUNPHARMA closed today lower at ₹1,796.2, a decrease of 0.5% from yesterday's close, completing a monthly decrease of -0.67% or ₹12.2. Over the past 12 months, SUNPHARMA stock lost -4.96%.
SUNPHARMA pays dividends to its shareholders, with the most recent payment made on Aug 08, 2025. The next estimated payment will be in In 2 months on Feb 08, 2026 for a total of ₹5.5.
The last earnings report, released on Nov 05, 2025, exceeded the consensus estimates by 1.03%. On average, the company has surpassed earnings expectations by 0.34%, based on the last three reports. The next scheduled earnings report is due on Jan 29, 2026.
Sun Pharmaceutical Industries Ltd. has completed 1 stock splits, with the recent split occurring on Jul 29, 2013.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
SUNPHARMA Chart
Similar
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) FAQ
What is the stock price today?
The current price is ₹1,796.20.
On which exchange is it traded?
Sun Pharmaceutical Industries Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is SUNPHARMA.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 20%.
What is its market cap?
As of today, the market cap is 4.26T.
What is the earnings per share?
The EPS is 12.6.
When is the next earnings date?
The next earnings report will release on Jan 29, 2026.
Has Sun Pharmaceutical Industries Ltd. ever had a stock split?
Sun Pharmaceutical Industries Ltd. had 1 splits and the recent split was on Jul 29, 2013.
Sun Pharmaceutical Industries Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | XNSE Exchange | INE044A01036 ISIN |
| India Country | 43,000 Employees | 7 Jul 2025 Last Dividend | 29 Jul 2013 Last Split | - IPO Date |
Overview
Sun Pharmaceutical Industries Limited is an established player in the generic pharmaceutical sector, engaged in the development, manufacture, and marketing of both branded and generic formulations along with active pharmaceutical ingredients (APIs). Since its inception in 1983, the company has expanded its footprint beyond its home ground in India to serve a global audience. Headquartered in Mumbai, India, Sun Pharmaceutical is committed to providing a wide range of healthcare solutions across numerous therapeutic areas, catering to diverse medical needs worldwide.
Products and Services
The company's portfolio is extensive, encapsulating a broad spectrum of therapeutic domains and ensuring healthcare needs are met comprehensively:
- Formulations: Sun Pharmaceutical delivers a variety of formulations across several key therapeutic areas. These include central nervous system disorders, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain management/analgesics, vitamins/minerals/nutrients, respiratory issues, gynaecology, urology, ophthalmology, orthopaedic care, nephrology, dental care, and more. Each area is covered with the aim to provide effective and accessible treatment options.
- Active Pharmaceutical Ingredients (APIs): The company manufactures APIs necessary for anti-cancer treatments, peptides, steroids, hormones, and immunosuppressant drugs. These APIs are critical components for a vast array of medicines, underscoring Sun Pharmaceutical's integral role in the global healthcare supply chain.
- Generic Medications: Offering an array of generic medications, Sun Pharmaceutical ensures affordability without compromising on quality. Their range includes tablets, capsules, injectables, inhalers, ointments, creams, and liquids. These generic options cater to various therapeutic needs, providing essential medications to a broader demographic.
- Specialty Medications and Antiretrovirals: The company also focuses on specialty medications, which address complex treatments, and antiretroviral medications for the management and treatment of HIV/AIDS. This segment underscores Sun Pharmaceutical’s commitment to addressing critical and specialist healthcare needs.
- Over-the-Counter Products: Sun Pharmaceutical's product range includes over-the-counter (OTC) products, making basic healthcare and wellness products accessible to the general public without the need for a prescription. This division complements their prescription-based medicines, offering a holistic approach to health and wellness.
Contact Information
Address: Sun House
Phone: 91 22 4324 4324
Website: https://www.sunpharma.com
2025 © Marketlog. All Rights Reserved.
